(Total Views: 297)
Posted On: 08/30/2019 9:50:52 AM
Post# of 27381
$PRTK News Article - The Lancet Infectious Diseases Publishes Results from Paratek's Phase 3 Oral only Dosing Study of NUZYRA (omadacycline) for Skin Infections https://marketwirenews.com/news-releases/the-...96615.html
(0)
(0)
My Twitter: WhyteStocks
